Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Medgenome Laboratories Pvt Ltd., Bangalore, India.
BMC Med Genet. 2020 Nov 2;21(1):216. doi: 10.1186/s12881-020-01153-4.
To determine the carrier frequency and pathogenic variants of common genetic disorders in the north Indian population by using next generation sequencing (NGS).
After pre-test counselling, 200 unrelated individuals (including 88 couples) were screened for pathogenic variants in 88 genes by NGS technology. The variants were classified as per American College of Medical Genetics criteria. Pathogenic and likely pathogenic variants were subjected to thorough literature-based curation in addition to the regular filters. Variants of unknown significance were not reported. Individuals were counselled explaining the implications of the results, and cascade screening was advised when necessary.
Of the 200 participants, 52 (26%) were found to be carrier of one or more disorders. Twelve individuals were identified to be carriers for congenital deafness, giving a carrier frequency of one in 17 for one of the four genes tested (SLC26A4, GJB2, TMPRSS3 and TMC1 in decreasing order). Nine individuals were observed to be carriers for cystic fibrosis, with a frequency of one in 22. Three individuals were detected to be carriers for Pompe disease (frequency one in 67). None of the 88 couples screened were found to be carriers for the same disorder. The pathogenic variants observed in many disorders (such as deafness, cystic fibrosis, Pompe disease, Canavan disease, primary hyperoxaluria, junctional epidermolysis bullosa, galactosemia, medium chain acyl CoA deficiency etc.) were different from those commonly observed in the West.
A higher carrier frequency for genetic deafness, cystic fibrosis and Pompe disease was unexpected, and contrary to the generally held view about their prevalence in Asian Indians. In spite of the small sample size, this study would suggest that population-based carrier screening panels for India would differ from those in the West, and need to be selected with due care. Testing should comprise the study of all the coding exons with its boundaries in the genes through NGS, as all the variants are not well characterized. Only study of entire coding regions in the genes will detect carriers with adequate efficiency, in order to reduce the burden of genetic disorders in India and other resource poor countries.
通过下一代测序(NGS)确定北印度人群中常见遗传疾病的携带频率和致病性变异。
在预测试咨询后,通过 NGS 技术对 88 个基因中的 200 个无关个体(包括 88 对夫妇)进行致病性变异筛查。根据美国医学遗传学学院的标准对变异进行分类。除了常规筛选外,还对致病性和可能致病性变异进行了基于文献的深入整理。未报告意义不明的变异。对个体进行咨询,解释结果的含义,并在必要时建议进行级联筛查。
在 200 名参与者中,发现 52 名(26%)个体携带一种或多种疾病。发现 12 名个体携带先天性耳聋,在测试的四个基因(SLC26A4、GJB2、TMPRSS3 和 TMC1,按降序排列)中,每 17 人就有一人携带该基因。发现 9 名个体携带囊性纤维化,携带频率为每 22 人就有一人。发现 3 名个体携带庞贝病(频率为每 67 人就有一人)。筛查的 88 对夫妇中没有一对携带相同的疾病。在许多疾病中观察到的致病性变异(如耳聋、囊性纤维化、庞贝病、Canavan 病、原发性高草酸尿症、交界性表皮松解症、半乳糖血症、中链酰基辅酶 A 缺乏症等)与西方常见的变异不同。
遗传耳聋、囊性纤维化和庞贝病的携带频率较高出乎意料,与亚洲印度人普遍认为的这些疾病的流行率相反。尽管样本量较小,但本研究表明,印度的基于人群的携带者筛查面板与西方的不同,需要谨慎选择。测试应包括通过 NGS 对基因的所有编码外显子及其边界进行研究,因为并非所有变异都得到很好的描述。只有通过 NGS 对基因的整个编码区域进行研究,才能以足够的效率检测到携带者,从而减少印度和其他资源匮乏国家遗传疾病的负担。